Hikma Pharmaceuticals Market Cap

Hikma Pharmaceuticals has a market cap or net worth of 4.43 billion as of July 18, 2025. Its market cap has increased by 10.38% in one year.

Market Cap

4.43B

Enterprise Value

5.31B

Revenue

2.50B

Ranking

n/a

PE Ratio

15.63

Stock Price

2,010.00

Market Cap Chart

Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 4.43B, an increase of 843.42%. That is a compound annual growth rate of 12.05%.

Market Cap History

Date	Market Cap	% Change
Jul 18, 2025	4.43B	0.25%
Dec 31, 2024	4.42B	11.74%
Dec 29, 2023	3.96B	15.72%
Dec 30, 2022	3.42B	-33.45%
Dec 31, 2021	5.14B	-11.50%
Dec 31, 2020	5.80B	20.30%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	159.63B
GSK plc	54.48B
Haleon	32.23B
Smith & Nephew	9.84B
ConvaTec Group	4.87B
HUTCHMED (China)	2.21B
Genus	1.58B
Indivior	1.49B

Market Cap Rankings